Regular article
Cell injury, repair, aging, and apoptosis
Mechanisms of Retinal Damage after Ocular Alkali Burns

https://doi.org/10.1016/j.ajpath.2017.02.005Get rights and content
Under an Elsevier user license
open archive

Alkali burns to the eye constitute a leading cause of worldwide blindness. In recent case series, corneal transplantation revealed unexpected damage to the retina and optic nerve in chemically burned eyes. We investigated the physical, biochemical, and immunological components of retinal injury after alkali burn and explored a novel neuroprotective regimen suitable for prompt administration in emergency departments. Thus, in vivo pH, oxygen, and oxidation reduction measurements were performed in the anterior and posterior segment of mouse and rabbit eyes using implantable microsensors. Tissue inflammation was assessed by immunohistochemistry and flow cytometry. The experiments confirmed that the retinal damage is not mediated by direct effect of the alkali, which is effectively buffered by the anterior segment. Rather, pH, oxygen, and oxidation reduction changes were restricted to the cornea and the anterior chamber, where they caused profound uveal inflammation and release of proinflammatory cytokines. The latter rapidly diffuse to the posterior segment, triggering retinal damage. Tumor necrosis factor-α was identified as a key proinflammatory mediator of retinal ganglion cell death. Blockade, by either monoclonal antibody or tumor necrosis factor receptor gene knockout, reduced inflammation and retinal ganglion cell loss. Intraocular pressure elevation was not observed in experimental alkali burns. These findings illuminate the mechanism by which alkali burns cause retinal damage and may have importance in designing therapies for retinal protection.

Cited by (0)

Supported by the Boston Keratoprosthesis Research Fund (E.I.P., C.Z., F.L., N.S., V.K., M.C.R., J.C., C.H.D.), Massachusetts Eye and Ear, the Eleanor and Miles Shore Fund (E.I.P.), the Massachusetts Lions Eye Research Fund (E.I.P.), a Research to Prevent Blindness (New York, NY) unrestricted grant (J.C.), and NIH National Eye Institute core grant P30EY003790.

E.I.P. and C.Z. contributed equally to this work.

Disclosures: None declared.